Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the safety and effectiveness of an experimental drug called human allogeneic mesenchymal stem cell therapy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04476901
Study type Interventional
Source University of Miami
Contact Shelly L Sayre, MPH
Phone 713-500-9529
Email Shelly.L.Sayre@uth.tmc.edu
Status Recruiting
Phase Phase 2
Start date May 7, 2021
Completion date December 2025

See also
  Status Clinical Trial Phase
Recruiting NCT06055504 - Study of Personalized Allocation of Defibrillators in Non-ischemic Heart Failure (SPANISH-1) N/A
Terminated NCT03249272 - Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve Phase 4
Recruiting NCT05769036 - Conventional Biventricular Versus Left Bundle Branch Pacing on Outcomes in Heart Failure Patients N/A
Recruiting NCT03797092 - Stem Cell Therapy in Non-IschEmic Non-treatable Dilated CardiomyopathiEs II: a Pilot Study Phase 1/Phase 2
Completed NCT01392625 - PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study) Phase 1/Phase 2
Not yet recruiting NCT05760924 - Left Bundle Branch Pacing on Outcomes and Ventricular Remodeling in Biventricular CRT Nonresponders N/A
Completed NCT04325594 - The Application of the Umbilical Cord Mesenchymal Stem Cells in the Complex Treatment of Non-ischemic Heart Failure Phase 2
Recruiting NCT04558723 - Cardiac Magnetic Resonance Guidance of Implantable Cardioverter Defibrillator Implantation in Non-ischemic Dilated Cardiomyopathy N/A